Sign in
SCHOLAR-1 versus ZUMA-1: A Standardized Comparison of Outcomes in Patients (Pts) with Refractory, Aggressive Non-Hodgkin Lymphoma (rNHL)
Journal article   Peer reviewed

SCHOLAR-1 versus ZUMA-1: A Standardized Comparison of Outcomes in Patients (Pts) with Refractory, Aggressive Non-Hodgkin Lymphoma (rNHL)

Sattva Neelapu, Frederick Locke, Nancy Bartlett, Lazaros Lekakis, Patrick Reagan, David Miklos, Caron Jacobson, Ira Braunschweig, Olalekan Oluwole, Tanya Siddiqi, …
Clinical lymphoma, myeloma and leukemia, Vol.17, pp.S362-S363
2017-09

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.214 PD-1
Web Of Science research areas
Hematology
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details